U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

On December 22, 2025, the U.S. Food and Drug Administration (FDA) formally approved Wegovy® pills, marking a major milestone in obesity treatment. The new medication from Novo Nordisk is designed as a ...

WeGovy is the first oral GLP drug for weight loss that will be on the market. The daily pill contains 25 milligrams of semaglutide to help fight obesity. Pharmacist Sam Durham said his pharmacy sells ...

The FDA has approved the first daily pill for obesity treatment, offering a new alternative to injectable weight loss drugs.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

A pill version of weight-loss drug Wegovy will be manufactured in the Triangle and could be available within weeks after the ...

Health-care companies rose amid optimism about obesity-drug demand.

Yesterday, the Food and Drug Administration (FDA) approved Novo Nordisk‘s (NYSE:NVO) Wegovy weight-loss pill, the first of its kind. This once-daily tablet uses the same active ingredient — ...

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

Amanda Bynes is celebrating a big win. On Tuesday, the former Nickelodeon star took to social media to post a rare paparazzi ...

GREENSBORO, N.C. — A major change is coming to weight loss treatment, and it starts in North Carolina. The Food and Drug Administration has approved the first pill version of Wegovy, a popular GLP-1 ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...